Candidate malaria vaccine shows promise A small medical trial conducted by a global team of researchers in Mali has found that a candidate malaria vaccine was secure and elicited strong immune responses in the 40 Malian adults who received it quite powerfull . The trial was the first to test this vaccine candidate, which is made to block the malaria parasite from getting into human bloodstream cells, in a malaria-endemic country. Predicated on these promising results, the research team is now conducting trials of this vaccine in 400 Malian kids aged 1 to 6 years. Malaria is usually a leading killer in Africa and other developing countries, claiming more than 1 million lives each complete year, most of them children.
Mike Lee tried to move a Senate quality that could have condemned illegal abortion practices. On Wednesday in a reaction to the case of Kermit Gosnell Lee asked unanimous consent to pass his resolution, a Philadelphia abortion doctor who’s on trial for performing unlawful and unsafe abortions . CQ HealthBeat: Health Panel Backs Drug Measures A House panel advanced procedures Wednesday to renew animal drug user fees also to overhaul the prescription medication supply chain. The Energy and Commerce Subcommittee on Wellness approved first, by tone of voice vote, a bill that would reauthorize user charges that fund the meals and Drug Administration's acceptance processes for brand-name and generic drugs for animals. Both current authorizations expire Oct. 1 . This content was reprinted from kaiserhealthnews.org with permission from the Henry J.